<DOC>
	<DOCNO>NCT01380587</DOCNO>
	<brief_summary>The purpose study determine utility XCL1 prognosis acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Utility XCL1 Prognostic Marker Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>Each year approximately 256,000 child adult around world develop form leukemia , 209,000 die . Recently , study evaluate relationship concentration cytokine prognosis acute lymphoblastic leukemia . XCL1 lymphotactin belongs cytokine subfamily call C Î³ one cysteine N-terminal residue . It find significant expression receptor mRNA XCL1 ( XCR1 ) T B lymphocytes related hematological neoplasm . For reason , XCL1 could efficient marker prognosis patient acute lymphoblastic leukemia .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>Patients newly diagnose acute lymphoblastic leukemia . Patients prior treatment chemotherapeutic agent . Patients treat immunosuppressant . Patients 12 month old . Patients diagnosis history autoimmune disease . Patients diagnosis history immunosuppressive disease . Patients agree sign Letter Informed Consent .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>ALL</keyword>
	<keyword>XCL1</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Prognosis</keyword>
</DOC>